14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $50.35 $57.15 Thursday, 2nd May 2024 INCY stock ended at $53.09. This is 0.283% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.26% from a day low at $52.28 to a day high of $53.46.
90 days $50.35 $61.87
52 weeks $50.27 $67.72

Historical Incyte Corporation prices

Date Open High Low Close Volume
Mar 27, 2024 $56.52 $57.30 $56.50 $57.12 1 463 986
Mar 26, 2024 $57.53 $57.56 $56.52 $56.55 1 610 260
Mar 25, 2024 $57.14 $57.59 $56.57 $57.48 1 841 460
Mar 22, 2024 $57.98 $57.98 $56.96 $56.98 1 152 421
Mar 21, 2024 $58.57 $59.03 $57.47 $57.72 1 503 966
Mar 20, 2024 $58.03 $58.41 $57.50 $58.24 1 698 646
Mar 19, 2024 $57.70 $58.44 $57.18 $58.33 2 428 899
Mar 18, 2024 $58.75 $58.75 $57.30 $57.34 1 785 973
Mar 15, 2024 $58.30 $58.76 $57.53 $58.37 3 589 431
Mar 14, 2024 $58.75 $59.11 $58.10 $58.54 1 215 038
Mar 13, 2024 $59.35 $60.22 $58.60 $58.92 1 313 637
Mar 12, 2024 $60.72 $60.90 $58.90 $59.33 1 552 153
Mar 11, 2024 $60.15 $61.16 $59.70 $60.79 2 110 289
Mar 08, 2024 $59.17 $60.17 $59.14 $60.02 1 432 956
Mar 07, 2024 $59.49 $59.72 $58.33 $59.03 1 355 064
Mar 06, 2024 $59.21 $59.70 $58.52 $59.26 1 752 338
Mar 05, 2024 $59.96 $60.19 $58.07 $58.90 1 855 727
Mar 04, 2024 $59.25 $59.78 $58.07 $59.72 1 604 459
Mar 01, 2024 $58.70 $59.66 $58.40 $59.05 1 477 123
Feb 29, 2024 $60.21 $60.21 $58.25 $58.36 2 726 612
Feb 28, 2024 $60.77 $61.00 $59.91 $59.98 1 092 561
Feb 27, 2024 $60.65 $61.41 $59.73 $61.00 1 250 419
Feb 26, 2024 $60.33 $61.44 $60.10 $60.53 1 195 032
Feb 23, 2024 $61.80 $61.87 $60.31 $60.59 1 349 426
Feb 22, 2024 $60.33 $61.27 $59.46 $60.91 1 673 864
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT